Bile acid, fibroblast growth factor-19, and glucagon-like peptide-1 levels in the long term after bariatric surgery in patients with type 2 diabetes

被引：0
|
作者：
Kim, M. [1 ]
机构：
[1] Catholic Univ Korea, Seoul, South Korea
来源：
DIABETOLOGIA | 2023年 / 66卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
544
引用
收藏
页码：S276 / S276
页数：1
相关论文
共 50 条
  • [21] Single-Dose Metformin Enhances Bile Acid-Induced Glucagon-Like Peptide-1 Secretion in Patients With Type 2 Diabetes
    Bronden, Andreas
    Alber, Anders
    Rohde, Ulrich
    Rehfeld, Jens F.
    Holst, Jens J.
    Vilsboll, Tina
    Knop, Filip K.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2017, 102 (11): : 4153 - 4162
  • [22] COPD Exacerbations in Patients With Type 2 Diabetes on Glucagon-like Peptide-1 Receptor Agonists
    Foer, D.
    Strasser, Z. H.
    Cui, J.
    Cahill, K. N.
    Murphy, S. N.
    Karlson, E. W.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 207
  • [23] Kidney Outcomes With Glucagon-Like Peptide-1 Receptor Agonists in Patients With Type 2 Diabetes
    Mosenzon, Ofri
    Schechter, Meir
    Leibowitz, Gil
    ADVANCES IN CHRONIC KIDNEY DISEASE, 2021, 28 (04) : 347 - 360
  • [24] Overview of Glucagon-Like Peptide-1 Receptor Agonists for the Treatment of Patients with Type 2 Diabetes
    Tran, Kelvin Lingjet
    Park, Young In
    Pandya, Shalin
    Muliyil, Navin John
    Jensen, Brandon David
    Huynh, Kovin
    Nguyen, Quang T.
    AMERICAN HEALTH AND DRUG BENEFITS, 2017, 10 (04): : 178 - 187
  • [25] Glucagon-like peptide-1 levels and dipeptidyl peptidase-4 activity in type 2 diabetes
    Senyigit, Abdulhalim
    Tabak, Omur
    Orbanoglu, Timur
    Karadag, Aytac
    Ugurlu, Serdal
    Uzun, Hafize
    Konukoglu, Dihlar
    CLINICAL AND INVESTIGATIVE MEDICINE, 2017, 40 (05): : E188 - E199
  • [26] FIBROBLAST GROWTH FACTOR-19 LEVELS IN TYPE 2 DIABETIC PATIENTS WITH METABOLIC SYNDROME
    Barutcuoglu, B.
    Basol, G.
    Cakir, Y.
    Cetinkalp, S.
    Parildar, Z.
    Kabaroglu, C.
    Ozmen, D.
    Mutaf, I.
    Bayindir, O.
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2011, 49 : S367 - S367
  • [27] Fibroblast Growth Factor-19 Levels in Type 2 Diabetic Patients with Metabolic Syndrome
    Barutcuoglu, Burcu
    Basol, Gunes
    Cakir, Yasemin
    Cetinkalp, Sevki
    Parildar, Zuhal
    Kabaroglu, Ceyda
    Ozmen, Dilek
    Mutaf, Isil
    Bayindir, Oya
    ANNALS OF CLINICAL AND LABORATORY SCIENCE, 2011, 41 (04): : 390 - 396
  • [28] Effects of Glucagon-Like Peptide-1 Analogue and Fibroblast Growth Factor 21 Combination on the Atherosclerosis-Related Process in a Type 2 Diabetes Mouse Model
    Kim, Jin Hee
    Lee, Gha Young
    Maeng, Hyo Jin
    Kim, Hoyoun
    Bae, Jae Hyun
    Kim, Kyoung Min
    Lim, Soo
    ENDOCRINOLOGY AND METABOLISM, 2021, 36 (01) : 157 - 170
  • [29] The Role of Glucagon-Like Peptide-1 Receptor Agonists in Type 2 Diabetes in Asia
    Ju-Ming Lu
    Advances in Therapy, 2019, 36 : 798 - 805
  • [30] Glucagon-like peptide-1 receptor agonists decreases albuminuria in overweight patients with type 2 diabetes
    Bulum, T.
    Blaslov, K.
    Tomic, M.
    Duvnjak, L.
    DIABETOLOGIA, 2015, 58 : S532 - S533
12345